Xenon Pharmaceuticals, Inc. (XENE)

41.50 +0.01 (+0.02%) USD  |  NASDAQ  |  Jan 21, 12:53
More

Xenon Pharmaceuticals Average Basic Shares Outstanding (5 Year Growth)

Average Basic Shares Outstanding (5 Year Growth) Chart

View Average Basic Shares Outstanding (5 Year Growth) for XENE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Average Basic Shares Outstanding (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Average Basic Shares Outstanding (5 Year Growth) Range, Past 5 Years

View Average Basic Shares Outstanding (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Average Basic Shares Outstanding (5 Year Growth) Benchmarks

View Average Basic Shares Outstanding (5 Year Growth) Benchmarks
Start Trial
Oncolytics Biotech, Inc. Upgrade
Aurinia Pharmaceuticals, Inc. Upgrade
Edesa Biotech, Inc. Upgrade
Lexaria Bioscience Corp. Upgrade
ProMIS Neurosciences, Inc. Upgrade